Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2022-12-12 History
Report ID 39237
Drug Identification Number 02407515
Brand name TARO-CARBAMAZEPINE
Common or Proper name TARO CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100'S
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-15
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-12-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v45 2021-10-21 French Compare
v44 2021-10-21 English Compare
v43 2021-10-13 French Compare
v42 2021-10-13 English Compare
v41 2021-09-15 French Compare
v40 2021-09-15 English Compare
v39 2021-08-24 French Compare
v38 2021-08-24 English Compare
v37 2021-08-20 French Compare
v36 2021-08-20 English Compare
v35 2021-08-04 French Compare
v34 2021-08-04 English Compare
v33 2019-08-19 French Compare
v32 2019-08-19 English Compare
v31 2019-04-24 French Compare
v30 2019-04-24 English Compare
v29 2019-04-15 French Compare
v28 2019-04-15 English Compare
v27 2019-03-15 French Compare
v26 2019-03-15 English Compare

Showing 21 to 40 of 65